Volume 14 Supplement 1
Towards clinical application of 7T TOF angiography
© Schmitter et al; licensee BioMed Central Ltd. 2012
Published: 1 February 2012
As shown at 7T Time-of-Flight (TOF) angiography significantly benefits from ultra high field (UHF) [1, 2], because of shorter T1 relaxation constant and increased SNR. However, significant challenges have to be overcome before using 7T TOF in clinical applications: I) RF induced specific absorption rate (SAR) substantially increases at UHF, preventing the use of standard RF pulses (venous Saturation (SAT), Magnetization Transfer (MT)) to improve TOF contrast. II) Severe transmit B1 (B1+) heterogeneity at 7T impairs contrast homogeneity.
SAR reduction with VERSE [3, 4] for excitation and travelling venous SAT pulses. The max amplitude of VERSE RF pulses was set to a fraction κEXC (or κSAT) of the max amplitude of initial excitation (or SAT) pulse. 2) Sparse application of MT  (10% of the centered k-space lines in phase and slab direction ).
Improved homogeneity of RF excitation profile with B1+ shimming (16 transmit channels), using fast multi channel B1+ calibration . The standard deviation divided by the mean (std/mean) of B1+ was minimized over the center slices of 3 TOF slabs using nonlinear optimization algorithms.
We demonstrate, with appropriate RF pulse design, substantial gains in contrast and B1+ homogeneity for TOF angiography at 7T. These results strongly support the potential of expanding non-contrast enhanced angiography at 7T towards clinical investigations.
ACKNOWLEDGEMENT: DFG: SCHM 2677/1, NIH P41 RR008079, P30 NS057091, R01 EB000331, NIH R21 EB009133; Keck Foundation.
- Kang : MRM. 2009, 61: 136-144.Google Scholar
- Zwanenburg : JMRI. 2008, 28: 1519-1526.Google Scholar
- Conolly : J Magn Reson. 1988, 78: 440-447.Google Scholar
- Schmitter : MRM. 2010, 64: 1447-1453.Google Scholar
- Parker : MRM. 1995, 34: 283-286.Google Scholar
- Schmitter : MRM.Google Scholar
- Van de Moortele : Proc. ISMRM. 2007, 1676-Google Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.